Registered number
12578145
REGENESIS ORTHOBIOLOGICS LIMITED
Filleted Accounts
31 March 2024
REGENESIS ORTHOBIOLOGICS LIMITED
Registered number: 12578145
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Current assets
Debtors 3 11,300 4,752
Cash at bank and in hand - 1,035
11,300 5,787
Creditors: amounts falling due within one year 4 (56,932) (52,811)
Net current liabilities (45,632) (47,024)
Net liabilities (45,632) (47,024)
Capital and reserves
Called up share capital 386 301
Profit and loss account (46,018) (47,325)
Shareholders' funds (45,632) (47,024)
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Fahad Gulamdastagir Attar
Director
Approved by the board on 7 June 2024
REGENESIS ORTHOBIOLOGICS LIMITED
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 4 3
3 Debtors 2024 2023
£ £
Other debtors 11,300 4,752
4 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts 92 -
Other taxes and social security costs 10,537 4,507
Other creditors 46,303 48,304
56,932 52,811
5 Controlling party
The director controls the company.
6 Other information
REGENESIS ORTHOBIOLOGICS LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
Suite 2 Parkway 5
Parkway Business Centre
300 Princess Road
Manchester
M14 7HR
REGENESIS ORTHOBIOLOGICS LIMITED 12578145 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts October 2023 release 2 Dr Fahad Gulamdastagir Attar No description of principal activity 12578145 2022-04-01 2023-03-31 12578145 core:WithinOneYear 2023-03-31 12578145 core:ShareCapital 2023-03-31 12578145 core:RetainedEarningsAccumulatedLosses 2023-03-31 12578145 2023-04-01 2024-03-31 12578145 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12578145 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 12578145 bus:Director40 2023-04-01 2024-03-31 12578145 1 2023-04-01 2024-03-31 12578145 2 2023-04-01 2024-03-31 12578145 countries:England 2023-04-01 2024-03-31 12578145 bus:FRS102 2023-04-01 2024-03-31 12578145 bus:FullAccounts 2023-04-01 2024-03-31 12578145 2024-03-31 12578145 core:WithinOneYear 2024-03-31 12578145 core:ShareCapital 2024-03-31 12578145 core:RetainedEarningsAccumulatedLosses 2024-03-31 12578145 2023-03-31 iso4217:GBP xbrli:pure